Welcome to our dedicated page for BullFrog AI Holdings SEC filings (Ticker: BFRGW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
BullFrog AI Holdings, Inc. filings document the regulatory record for an AI-enabled drug discovery company with Nasdaq-listed common stock and tradeable warrants. Recent 8-K reports cover business updates, commercial-stage platform activity, Nasdaq stockholders’ equity compliance, at-the-market and equity-line financing facilities, and other material events.
Proxy materials describe annual-meeting procedures, shareholder voting matters, director-nomination deadlines, board governance, and outstanding common-stock information. The filing record also references platform disclosures for bfLEAP® and related AI workflows that support biomedical data analysis, target prioritization, and clinical-development decision processes.
BullFrog AI Holdings, Inc. amends its shelf to permit at-the-market sales of up to $4.3 million of common stock under its existing Sales Agreement with BTIG, LLC. The supplement states the company’s Public Float is approximately $27.0 million based on 18,447,105 shares outstanding as of April 1, 2026, with about 16.0 million held by non-affiliates. The filing notes prior ATM sales of approximately $4.7 million during the prior 12-calendar month period and that one-third of the Public Float equals about $9.0 million, leaving $4.3 million available under General Instruction I.B.6 of Form S-3. Sales will be made "at the market" on mutually agreed terms and the supplement is qualified by the underlying ATM Prospectus.
BullFrog AI Holdings, Inc. reports that it has raised at least $3.45 million in net proceeds from sales of common stock under its at-the-market sales agreement and equity line of credit facility. The company states that, as a result, it now believes its stockholders’ equity exceeds $2.5 million, the minimum required by Nasdaq Listing Rule 5550(b)(1) for listing on The Nasdaq Capital Market.
The company had previously requested a hearing before an independent Nasdaq Hearings Panel regarding its prior stockholders’ equity deficiency. It cautions that statements about the outcome of any Nasdaq hearing and its ability to regain or maintain listing compliance are forward-looking and subject to risks and uncertainties.
BullFrog AI Holdings, Inc. entered into a one-year Feasibility Agreement with a top global pharmaceutical company to use its bfLEAP® AI and machine learning platform to identify and prioritize novel drug targets for major depressive disorder (MDD). BullFrog AI can earn milestone payments tied to specific deliverables, and the client receives an option for exclusive rights to a selected final target candidate for three years for its own research and development. The agreement is terminable on notice and includes customary protections around intellectual property, indemnification, and confidentiality. A related press release highlights this as high-profile validation of BullFrog AI’s platform in an MDD market valued at more than $8 billion in 2025 and projected to exceed $11 billion by 2032.
BullFrog AI Holdings, Inc. is an early-stage AI-driven biopharmaceutical company using its proprietary bfLEAP™, BullFrog Data Networks™ and bfPREP™ platforms to analyze complex biomedical data and improve drug discovery, rescue failed drugs and support precision medicine development.
The company licenses oncology and liver-disease assets from Johns Hopkins University and George Washington University and maintains multiple royalty-bearing technology licenses with significant future milestone and minimum royalty obligations. It is expanding its data offerings through collaborations, including Lieber Institute for Brain Development and Eleison Pharmaceuticals, and plans to launch a scenario-based decision engine in March 2026.
The filing highlights serious financial and listing risks: as of December 31, 2025, BullFrog held about $2.3 million in cash with an accumulated deficit of roughly $23.3 million, and its auditors expressed substantial doubt about its ability to continue as a going concern. Nasdaq has notified the company of noncompliance with both the stockholders’ equity and minimum bid price requirements, and BullFrog is pursuing an appeal and considering options such as a reverse stock split already approved by stockholders.
BullFrog AI Holdings, Inc. reports that Nasdaq has determined the company did not meet the terms of a previously granted extension to regain compliance with the Nasdaq Listing Rule 5550(b)(1), which requires at least $2,500,000 in stockholders’ equity for continued listing on the Nasdaq Capital Market.
As a result, the company’s common stock and tradeable warrants are now subject to potential delisting. BullFrog AI intends to promptly request a hearing before an independent Nasdaq Hearings Panel, which will temporarily stay any suspension or delisting while the hearing process and any Panel-granted extension are in effect.
The company plans to present additional details of its compliance plan and seek more time to meet all applicable Nasdaq listing rules. It cautions that there is no assurance the Panel will grant extra time or that it will ultimately regain compliance. The filing notes that delisting could make trading more difficult, pressure the share and warrant prices, and impair the company’s ability to raise capital.
BullFrog AI Holdings reported that Nasdaq notified the company on February 10, 2026 that its common stock had closed below $1.00 per share for 30 consecutive business days, triggering a deficiency under Nasdaq’s Minimum Bid Price Requirement.
The notice does not immediately affect trading, and the common stock will continue on the Nasdaq Capital Market under “BFRG” and warrants under “BFRGW”. The company has 180 calendar days, until August 10, 2026, to regain compliance by maintaining a closing bid of at least $1.00 for ten consecutive business days. A second 180-day period may be available if other listing standards are met and the company indicates it may use tools such as a reverse stock split. If compliance is not regained, the securities could be delisted, though the company would have appeal rights.
BullFrog AI Holdings, Inc. filed an 8-K disclosing an amendment to its bylaws, effective September 18, 2025. The filing furnishes Exhibit 3.1, the amendment to the bylaws, and includes a Cover Page Interactive Data File formatted as Inline XBRL. The document is signed by Vininder Singh, Chief Executive Officer. The body of the filing provided here contains exhibit and filing metadata and does not include the text of the bylaw amendment itself or explanatory detail about the amendment's purpose or effects.
BullFrog AI Holdings, Inc. reported that it received a Nasdaq notice on August 21, 2025 stating the company no longer meets the Nasdaq Capital Market stockholder equity requirement. Nasdaq cited stockholders’ equity of $2,188,110 as of the quarter ended June 30, 2025, below the required $2,500,000. Trading in the company’s common stock (BFRG) and tradable warrants (BFRGW) continues for now while the company works on a compliance plan.
The company has 45 days to submit a plan to regain compliance and may receive up to 180 days from the notice date to demonstrate sufficient equity. If it fails, its common stock and warrants could be delisted, though Nasdaq rules allow an appeal. Separately, the board approved one-time equity retention awards for executives and directors, made under the 2022 Equity Compensation Plan. These awards are split 33% immediately vested stock and 67% restricted stock units, which vest 50% on each of September 1, 2026 and September 1, 2027, with an aggregate of 267,842 shares underlying the awards if all RSUs vest.
Jason Hanson, a director of BullFrog AI Holdings, Inc. (ticker BFRG/BFRGW), received equity awards consisting of 2,813 fully vested shares of common stock and 5,710 restricted stock units (RSUs). The RSUs vest in two equal tranches, with 50% vesting on September 1, 2026 and the remaining 50% on September 1, 2027, and convert to one share each when settled. The RSU forfeiture restrictions will accelerate upon a defined change in control or a significant financing. After these grants, Hanson beneficially owns 8,523 shares in total, held directly.
Vininder Singh, who serves as Chief Executive Officer, a director and a reported >10% owner of BullFrog AI Holdings, acquired equity awards under the Company’s 2022 Equity Compensation Plan. The filing reports an acquisition of 75,000 shares of Common Stock issued as an equity grant that were fully vested upon grant, and 152,273 Restricted Stock Units (RSUs) that vest 50% on September 1, 2026 and 50% on September 1, 2027. Each RSU represents a contingent right to one share of Common Stock. The report shows 2,367,446 shares of Common Stock beneficially owned following the transaction. RSU forfeiture restrictions will lapse earlier if a change in control or a significant financing occurs, per the Plan.